Blood pressure management guidelines have shifted significantly in recent years, reflecting new evidence about optimal control targets. The changes follow landmark clinical trials and represent an evolving understanding of how aggressive treatment can benefit patient outcomes, particularly for cognitive health.
For more than 25 years, a blood pressure reading of 140/90 or below was considered normal. However, the 2017 update by the American Heart Association and American College of Cardiology introduced major changes based on the landmark SPRINT trial. This trial enrolled adults over 50 at high cardiovascular risk and found that intensive treatment aiming for systolic readings below 120 reduced the risk of heart attacks, strokes, other cardiovascular illnesses, and overall mortality so substantially that investigators stopped the study early.
The 2017 guidelines recommended medication for those with systolic blood pressure over 130. The most recent revisions, issued last year, encourage even tighter control. They call for patients at cardiovascular risk to strive for systolic readings below 120 and call that target “reasonable” even for those not at high risk.
For older adults, recent evidence showing cognitive benefits from lower readings has influenced clinical practice. As geriatrician Mark Supiano notes: “What’s good for the heart is good for the brain.” Studies in the United States and China show cognitive benefits for the lower readings in older populations. Nearly all major medical associations, including the American Geriatrics Society, have endorsed the latest guidelines.
However, important practical considerations remain. Blood pressure varies throughout the day depending on activity, food intake, and external circumstances. Systolic readings can fluctuate by 30 points or more in a single day and are almost always higher in a doctor’s office. The new guidelines therefore recommend at-home monitoring, with patients recording blood pressure twice daily for one or two weeks before appointments.
Treatment typically requires two or three drugs, but generic blood pressure medications cost about $5 per month and rarely interact with other medications commonly prescribed for older people. Potential side effects include falls from hypotension, though studies show fall rates were similar between intensive and standard treatment groups even among those over 75.
For patients with other serious illnesses—cancer patients or frail nursing home residents with dementia—blood pressure control may be far down the list of priorities. Additionally, meta-analysis data shows that preventing a single stroke in intensive hypertension treatment takes an average of 1.7 years. Individual clinical judgment remains important alongside guideline recommendations.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.timescall.com/2026/04/13/blood-pressure-control-guidelines/